Interventional treatment for bronchopleural fistula in osteosarcoma lung metastases
Part of Cancer, Lungs & breathing clinical trials.
This study reviews how well a minimally invasive procedure (blocking abnormal blood vessels) works for people with osteosarcoma that has spread to the lungs and caused a bronchopleural fistula, a rare connection between the airway and the chest cavity. It may help if standard treatments haven't controlled symptoms like coughing up blood or lung infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with osteosarcoma that has spread to your lungs.
- You have a bronchopleural fistula confirmed by imaging (CT or PET-CT scan).
- You have symptoms like coughing up blood, a collapsed lung, or ongoing chest infection that haven't improved with standard care.
- You are 75 years old or younger and in generally good health (ECOG score 0–2).
- Your blood clotting is basically normal.
- Your doctor has confirmed via angiography that the abnormal blood vessels can be safely blocked.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether the combination of two drugs, apatinib (a targeted therapy) and liposomal irinotecan (a chemotherapy), can help people with osteosarcoma that has not responded to standard treatments or has spread. The goal is to see if the combination can shrink tumors or slow the disease.
This trial tests a combination of immunotherapy and targeted radiation before surgery for osteosarcoma that has spread to the lungs. It aims to see if this approach can help shrink or control the lung tumors and make surgery more effective.
This trial tests a treatment called bronchial artery chemoembolization (BACE) combined with drug therapy for advanced non-small cell lung cancer. BACE delivers chemotherapy directly to the tumor through the blood vessel that feeds it, which may help control the cancer when standard treatments have stopped working.
This trial tests whether combining an immunotherapy drug (atezolizumab) with focused radiation and surgery can help people whose osteosarcoma has come back only in the lungs. It aims to see if this approach is safe and may improve outcomes.
This early-phase study tests a special way to deliver medicine directly to the lungs (called IVLP) for sarcoma that has spread to both lungs. It aims to control lung metastases while reducing side effects, and it uses a plan that often includes surgery or focused radiation around the procedure.
This study tests a radiation treatment called brachytherapy, which delivers a high dose of radiation directly to the tumor. It is for people with osteosarcoma that cannot be removed by surgery and has not responded to other treatments. The goal is to shrink the tumor and control symptoms.
Hear when a new Osteosarcoma Metastatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.